The Boston Hemophilia Center is dedicated to advancing understanding and treatment of hemophilia.
Our investigators and other researchers throughout Dana-Farber/Children's Hospital Cancer Center participate in large, multi-center research studies, as well as lead smaller independent initiatives to help improve treatment.
We currently offer several active clinical research studies for bleeding disorders, and others are in the process of development and approval. Current studies are available to children or adults with hemophilia A, hemophilia B, hemophilia with inhibitors, von Willebrand's disease, women with bleeding disorders, knee replacement surgery and factor XIII deficiency.
To learn more about the studies that are going on at our Center, please contact Stephanie Slate, Clinical Research Coordinator, at 617-355-6863.